(Q39876126)

15 September 2017

title

Bmf is upregulated by PS-341-mediated cell death of glioma cells through JNK phosphorylation (English)

1 reference

15 September 2017

1 reference

1 reference

Zheng Tianhu

1

1 reference

15 September 2017

Zhao Shiguang

series ordinal

2

1 reference

15 September 2017

Liu Xinghan

series ordinal

3

1 reference

15 September 2017

publication date

7 March 2009

1 reference

Molecular Biology Reports

15 September 2017

published in

1 reference

15 September 2017

volume

37

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

1211-1219

1 reference

Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction

15 September 2017

cites work

1 reference

12 December 2020

Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression

1 reference

12 December 2020

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

1 reference

12 December 2020

Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent.

1 reference

12 December 2020

Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib

1 reference

12 December 2020

Proteasome inhibition: a new strategy in cancer treatment

1 reference

12 December 2020

The Bcl-2 family: roles in cell survival and oncogenesis.

1 reference

12 December 2020

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

1 reference

12 December 2020

Cell death: critical control points

1 reference

12 December 2020

The proteasome inhibitor bortezomib stabilizes a novel active form of p53 in human LNCaP-Pro5 prostate cancer cells

1 reference

12 December 2020

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

1 reference

12 December 2020

Proteasome inhibitors as new anticancer drugs

1 reference

12 December 2020

Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.

1 reference

12 December 2020

Approval summary for bortezomib for injection in the treatment of multiple myeloma

1 reference

12 December 2020

Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis

1 reference

12 December 2020

PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells

1 reference

12 December 2020

BCL-2 family regulation by the 20S proteasome inhibitor bortezomib

1 reference

12 December 2020

Ways of dying: multiple pathways to apoptosis.

1 reference

12 December 2020

Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.

1 reference

12 December 2020

Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling

1 reference

12 December 2020

The proteasome: a novel target for cancer chemotherapy

1 reference

12 December 2020

Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak

1 reference

12 December 2020

The proteasome inhibitor bortezomib (PS-341) inhibits growth and induces apoptosis in primary effusion lymphoma cells

1 reference

12 December 2020

Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy.

1 reference

12 December 2020

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

1 reference

12 December 2020

The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype

1 reference

12 December 2020

Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors

1 reference

12 December 2020

Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM).

1 reference

12 December 2020

Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis

1 reference

12 December 2020

BH3-Only proteins-essential initiators of apoptotic cell death

1 reference

12 December 2020

When protein destruction runs amok, malignancy is on the loose

1 reference

12 December 2020

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

1 reference

12 December 2020

Effects of the proteasome inhibitor PS-341 on apoptosis and angiogenesis in orthotopic human pancreatic tumor xenografts.

1 reference

12 December 2020

Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins.

1 reference

12 December 2020

Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin

1 reference

12 December 2020

JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis

1 reference

12 December 2020

10.1007/S11033-009-9491-9

Identifiers

DOI

1 reference

15 September 2017

1 reference